FindTrial
Sign In

The study of absorption of the Siddha drug Madhumega Chooranam in animals and in healthy individuals.

Pharmacokinetic study on the Siddha Polyherbal formulation, Madhumega Chooranam (MMC) in preclinical and in clinical settings

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/12/010977
Enrollment
10
Registered
2017-12-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Madhumega chooranam,: Polyherbal siddha formulation,Madhumega chooranam, 3gms single dose for 24 hours Control Intervention1: Not applicable: Not applicable

Sponsors

Dr C Anbarasi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age â?? 20-40 years Gender â?? both sex Normal healthy volunteers willing to give voluntary written informed consent

Exclusion criteria

Exclusion criteria: Pregnant and lactating mother HIV infected Cancer Organ damage Recently blood donated (within 3 months)

Design outcomes

Primary

MeasureTime frame
Pharmacokinetic parameters: Maximum drug concentration in the blood (C max) Minimum drug concentration in the blood (C min) Time to reach maximum blood concentration (t max) Half-life (t ½) Timepoint: 24 hours—

Secondary

MeasureTime frame
ascertain the dose and frequency of drug intakeTimepoint: 24 hours—

Countries

India

Contacts

Public ContactDr C Anbarasi

Sri Ramachandra University

stsrmc@yahoo.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026